ATLAS / Macro Radar / Reporting / DYN

Dyne Therapeutics, Inc. (DYN) reporting calendar

Dyne Therapeutics, Inc. files periodic reports with the SEC as DYN on Nasdaq. Atlas tracks 23 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 27 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
11 May 2026
Reports on record
23

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open DYN market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202611 May 202641 days0001193125-26-215702
10-K31 Dec 20252 Mar 202661 days0001193125-26-084178
10-Q30 Sep 20255 Nov 202536 days0001193125-25-266882
10-Q30 Jun 202528 Jul 202528 days0000950170-25-099161
10-Q31 Mar 20258 May 202538 days0000950170-25-066386
10-K31 Dec 202427 Feb 202558 days0000950170-25-028356
10-Q30 Sep 202412 Nov 202443 days0000950170-24-124572
10-Q30 Jun 202412 Aug 202443 days0000950170-24-095527
10-Q31 Mar 20242 May 202432 days0000950170-24-052066
10-K31 Dec 20235 Mar 202465 days0000950170-24-025402
10-Q30 Sep 202330 Oct 202330 days0000950170-23-056121
10-Q30 Jun 20233 Aug 202334 days0000950170-23-037585
10-Q31 Mar 202311 May 202341 days0000950170-23-020839
10-K31 Dec 20222 Mar 202361 days0000950170-23-005708
10-Q30 Sep 20223 Nov 202234 days0000950170-22-021546
10-Q30 Jun 20224 Aug 202235 days0000950170-22-014474
10-Q31 Mar 20222 May 202232 days0000950170-22-006860
10-K31 Dec 202110 Mar 202269 days0000950170-22-003290
10-Q30 Sep 20214 Nov 202135 days0000950170-21-002933
10-Q30 Jun 20215 Aug 202136 days0001564590-21-041177
10-Q31 Mar 20216 May 202136 days0001564590-21-024523
10-K31 Dec 20204 Mar 202163 days0001564590-21-010726
10-Q30 Sep 20205 Nov 202036 days0001564590-20-050870

Source: SEC EDGAR company submissions for CIK 0001818794. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.